United Therapeutics (UTHR) Return on Sales [ROS] (2009 - 2026)
United Therapeutics (UTHR) reported Return on Sales [ROS] of 42.23% for Q2 2026, down 3.41 percentage points from 45.64% a year earlier but up 0.54 percentage points from the prior quarter.
Powered by 
Analysis
United Therapeutics (UTHR) Return on Sales [ROS] (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, United Therapeutics' Return on Sales [ROS] came in at 44.44%, down 2.61 percentage points year-over-year; for FY2025, it came in at 46.89%, down 0.96 percentage points from FY2024.
- Return on Sales [ROS] has a five-year change of +6.88 percentage points (FY2020 to FY2025).
- By year, Return on Sales [ROS] came in at 47.86% in FY2024 (-3.05 pp), 50.91% in FY2023 (+0.31 pp), 50.60% in FY2022 (+17.62 pp) and 32.98% in FY2021 (-7.04 pp).
- Five-year quarterly Return on Sales [ROS] spans a low of 35.73% in Q4 2022 and a high of 62.35% in Q1 2022.
- Year over year, Return on Sales [ROS] has now declined in each of the last three quarters, with an average year-over-year change of -1.96 percentage points over the last eight quarters.
- The high point for year-over-year Return on Sales [ROS] in five years was Q1 2022 (a gain of 79.44 percentage points); the low point was Q3 2024 (a drop of 7.85 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 41.69% (Q1 2026), 45.14% (Q4 2025) and 48.59% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | United Therapeutics | 23.12 Bn | 12.61 Bn | 683.80 Mn | 42.23% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.23% |
| Mar 31, 2026 | 41.69% |
| Dec 31, 2025 | 45.14% |
| Sep 30, 2025 | 48.59% |
| Jun 30, 2025 | 45.64% |
| Mar 31, 2025 | 48.19% |
| Dec 31, 2024 | 48.61% |
| Sep 30, 2024 | 45.81% |
| Jun 30, 2024 | 44.75% |
| Mar 31, 2024 | 52.57% |
| Dec 31, 2023 | 42.31% |
| Sep 30, 2023 | 53.66% |
| Jun 30, 2023 | 52.54% |
| Mar 31, 2023 | 56.11% |
| Dec 31, 2022 | 35.73% |
| Sep 30, 2022 | 60.91% |
| Jun 30, 2022 | 43.22% |
| Mar 31, 2022 | 62.35% |
| Dec 31, 2021 | 40.90% |
| Sep 30, 2021 | 51.43% |
API Access
United Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=UTHR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "UTHR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=UTHR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();